GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ortin Global Ltd (NSE:ORTINGLOBE) » Definitions » Book Value per Share

Ortin Global (NSE:ORTINGLOBE) Book Value per Share : ₹0.00 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Ortin Global Book Value per Share?

Ortin Global's book value per share for the quarter that ended in Dec. 2024 was ₹0.00.

During the past 12 months, Ortin Global's average Book Value Per Share Growth Rate was -77.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -37.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -31.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -14.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Ortin Global was 3.60% per year. The lowest was -37.10% per year. And the median was -12.60% per year.

Ortin Global's current price is ₹10.86. Its book value per share for the quarter that ended in Dec. 2024 was ₹0.00. Hence, today's PB Ratio of Ortin Global is .

During the past 13 years, the highest P/B Ratio of Ortin Global was 7.42. The lowest was 0.25. And the median was 0.78.

Good Sign:

Ortin Global Ltd stock PB Ratio (=4.07) is close to 1-year low of 4.07.


Ortin Global Book Value per Share Historical Data

The historical data trend for Ortin Global's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortin Global Book Value per Share Chart

Ortin Global Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.29 13.97 13.48 13.36 3.47

Ortin Global Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3.47 - 2.77 -

Competitive Comparison of Ortin Global's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Ortin Global's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ortin Global's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ortin Global's PB Ratio distribution charts can be found below:

* The bar in red indicates where Ortin Global's PB Ratio falls into.


;
;

Ortin Global Book Value per Share Calculation

Ortin Global's Book Value Per Share for the fiscal year that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(28.24-0.00)/8.13
=3.47

Ortin Global's Book Value Per Share for the quarter that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(N/A-0.00)/8.13
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Ortin Global  (NSE:ORTINGLOBE) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Ortin Global Book Value per Share Related Terms

Thank you for viewing the detailed overview of Ortin Global's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Ortin Global Business Description

Traded in Other Exchanges
Address
Road No.12, Mayfair Gardens, 8-2-682/3/A & 3B, Flat No. 201, 2nd Floor, Banjara Hills, Khairatabad, Hyderabad, TG, IND, 500034
Ortin Global Ltd is an Indian company engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its API intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zudavudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others. The company has two operating segments, including Manufacture and Trading. The company generates the majority of its revenue from the Trading division, which involves trading of Pharmaceuticals and medical Formulations.

Ortin Global Headlines

No Headlines